Zura Bio Reports $187.70 Million in Cash, Funds Operations Through 2028
Zura Bio reported cash and cash equivalents of $187.70 million as of September 30, 2026, which it says funds operations through 2028.
Related stories
The United States Small-cap Stock Market Index (2000) Hit 5-week High
US Index 2000 increased to 2865.00 Index Points, the highest since September 2026. Over the past 4 weeks, United States Small-cap Stock Market Index (2000) gained 2.38%, and in the
L impact | EQUITY | Oct 29, 2026, 02:04 PM UTC
LKQ Shares Rise Despite Lower Q3 Adjusted Earnings and Revenue
LKQ shares were up over 3% in early Thursday trading despite lower third-quarter adjusted earnings and revenue.
M impact | EQUITY | Oct 29, 2026, 02:03 PM UTC
Fortrea Shares Fall More Than 10% After Q3 Results
Fortrea shares fell more than 10% in early morning trading after the company reported Q3 results.
M impact | EQUITY | Oct 29, 2026, 02:03 PM UTC
Jordan Press and Publishing Q3 revenue 989,360 dinars
M impact | EQUITY | Oct 29, 2026, 02:03 PM UTC
Analysts Raise Price Targets for ICON After Q3 Earnings
Deutsche Bank raised its ICON target to $250 from $200, RBC to $226 from $185, and Truist Securities to $268 from $209. All three firms maintained their existing Buy or Outperform
M impact | EQUITY | Oct 29, 2026, 02:03 PM UTC
Baldwin Group Reports 8% Fall in Commercial Property Insurance Pricing
Commercial property insurance pricing fell 8% in Q3 2026, Baldwin Group reported.
M impact | EQUITY | Oct 29, 2026, 02:03 PM UTC